Presa, Jessica
Carrico, Ruth
Fergie, Jaime E.
Hanenberg, Stephanie
Marshall, Gary S.
Rivard, Kaitlyn
Shaw, Jana
Zimet, Gregory D.
Peyrani, Paula
Cane, Alejandro
Funding for this research was provided by:
Pfizer Inc
Article History
Received: 16 October 2024
Accepted: 8 May 2025
First Online: 3 June 2025
Declarations
:
: The following authors received honoraria from Pfizer Inc to attend the 2022 ARTEMIS meeting: Ruth Carrico, Jaime E. Fergie, Stephanie Hanenberg, Gary S. Marshall, Kaitlyn Rivard, Jana Shaw, and Gregory D. Zimet. Ruth Carrico is a consultant and advisory board member for Pfizer, Moderna, Sanofi, and Novavax, and a speaker for Pfizer. Jaime E. Fergie is a consultant and speaker for Pfizer, Sanofi, and GSK and a consultant for Moderna, Novavax, and Merck. Gary S. Marshall has received grants and/or contracts (paid to the institution) from GSK, Merck, Pfizer, Sanofi, and Seqirus. He further discloses advisory board participation, consulting fees, and travel/meeting support from GSK, Merck, Moderna, Pfizer, Sanofi, and Seqirus. Kaitlyn Rivard serves as an advisory board member for Pfizer and is a paid consultant for Wolters Kluwer. Jana Shaw is a consultant and speaker for Pfizer Inc, and a consultant for GSK. Gregory D. Zimet has served as an external advisory board member for Merck, Pfizer, and Moderna and as a consultant to Merck; has received investigator-initiated research funding from Merck administered through Indiana University; and serves as an unpaid member of the Board of Directors for the Unity Consortium, a nonprofit organization that supports adolescent health through vaccination. Jessica Presa, Paula Peyrani, and Alejandro Cane are current employees of Pfizer and may have stock or stock options.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.